NBIX vs SD · P/E 45, rev $2.36B vs P/E 6.9, rev $125.3M
Neurocrine Biosciences Inc (NBIX) versus SandRidge Energy Inc (SD) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
SandRidge Energy Inc (SD) is a oil & gas e&p company listed on NYSE.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported SD revenue for 2024-12-31 was $125.3M. Net income was $63.0M. Revenue was down 15.7% from 2023-12-31 to 2024-12-31. SD currently screens at market cap $522.0M and trailing P/E 6.9.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. SD currently screens at market cap $522.0M and trailing P/E 6.9.
Not investment advice. Open the NBIX and SD stock pages for the full models.
Not investment advice.